BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
BillionToOne, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$101.03+2.91 (+2.97%)
Close on Oct 19, 2026
- Market cap
- $5.50B
- P/E (TTM)
- 721.6
- Dividend yield
- –
Share price
+$101.02 (+1,010,200%)past year
Weekly closes, adjusted for splits. Drag across the chart to measure a change.Earnings
BillionToOne, Inc. grew revenue 90.1% to $397.41M over the twelve months to Jun 30, 2026. Free cash flow was $33.17M.
Revenue
$397.41M
+90.1% vs. a year earlier
Operating income
$43.30M
TTM Q2 2026
Free cash flow
$33.17M
TTM Q2 2026
EPS, diluted
$0.14
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $5.50B
- P/E ratio
- 721.6
- Price to sales
- 13.84
- Price to book
- 10.25
- Dividend yield
- –
- Free cash flow yield
- 0.60%
Fundamentals
- Revenue
- $397.41M
- Net income
- $37.71M
- EPS, diluted
- $0.14
- Free cash flow
- $33.17M
- Book value per share
- $9.86
- Diluted shares
- 54M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$397.41M+90.1% YoY
Gross profit
$283.22M+122.4% YoY
Operating income
$43.30M
Net income
$37.71M
EPS, diluted
–
Free cash flow
$33.17M
Reported periodTrailing twelve months